PRDX2 and cancer: Given that peroxiredoxin 2 (PRDX2) reduces ROS production and contributes to anti-apoptotic mechanisms in cancer cells, molecular docking techniques suggest that triptolide binds to PRDX2 at the Cys172 site, directly hindering PRDX2’s function.